We are live on ! Find out more
USNA icon

Usana Health Sciences

162 hedge funds and large institutions have $290M invested in Usana Health Sciences in 2025 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 21

26% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 47

12% more call options, than puts

Call options by funds: $232K | Put options by funds: $207K

7% more funds holding

Funds holding: 152162 (+10)

0.29% more ownership

Funds ownership: 56.57%56.86% (+0.29%)

25% less capital invested

Capital invested by funds: $387M → $290M (-$97M)

Holders
162
Holders Change
+10
Holders Change %
+6.58%
% of All Funds
2.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
59
Reduced
47
Closed
21
Calls
$232K
Puts
$207K
Net Calls
+$25K
Net Calls Change
+$57K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$49.6M -$100K -3,162 -0.2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$37.1M -$5.47M -172,782 -11%
Pzena Investment Management
3
Pzena Investment Management
New York
$29.5M +$257K +8,110 +0.7%
Renaissance Technologies
4
Renaissance Technologies
New York
$29.3M -$177K -5,600 -0.5%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$23M +$2.48M +78,432 +10%
State Street
6
State Street
Massachusetts
$12.2M +$5.48K +173 +0%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$8.64M +$580K +18,305 +6%
Morgan Stanley
8
Morgan Stanley
New York
$8.06M +$2.89M +91,182 +44%
American Century Companies
9
American Century Companies
Missouri
$6.88M +$679K +21,445 +9%
Jacobs Levy Equity Management
10
Jacobs Levy Equity Management
New Jersey
$5.08M +$1.88M +59,535 +46%
Charles Schwab
11
Charles Schwab
California
$4.69M +$1.05M +33,141 +24%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$3.96M -$1.94M -61,136 -29%
Citadel Advisors
13
Citadel Advisors
Florida
$3.73M +$217K +6,868 +5%
Northern Trust
14
Northern Trust
Illinois
$3.63M -$45.7K -1,443 -1%
Millennium Management
15
Millennium Management
New York
$3.5M +$3.55M +111,973 +635%
Pacer Advisors
16
Pacer Advisors
Pennsylvania
$3.44M -$14.7M -464,507 -78%
Invesco
17
Invesco
Georgia
$3M -$158K -5,006 -4%
Assenagon Asset Management
18
Assenagon Asset Management
Luxembourg
$2.82M -$122K -3,854 -4%
Ameriprise
19
Ameriprise
Minnesota
$2.46M +$462K +14,593 +19%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$2.27M -$6.62K -209 -0.2%
Goldman Sachs
21
Goldman Sachs
New York
$2.06M -$758K -23,948 -24%
Man Group
22
Man Group
United Kingdom
$1.86M +$1.51M +47,836 +228%
UBS Group
23
UBS Group
Switzerland
$1.63M -$789K -24,931 -29%
Principal Financial Group
24
Principal Financial Group
Iowa
$1.49M +$46.6K +1,473 +3%
Bank of America
25
Bank of America
North Carolina
$1.47M +$1.12M +35,233 +182%

USNA Hedge Fund Activity: Q1 2025 in Review

162 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2025, worth a combined $290M — down 25% from $387M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new USNA positions and 21 closed out — a net gain of 10 holders — while 59 added to existing stakes and 47 trimmed.

The largest buyer was Millennium Management, adding an estimated $3.55M. The largest seller was Pacer Advisors, cutting an estimated $14.7M.

  • 162 institutional investors held Usana Health Sciences (USNA) as of Q1 2025, up from 152 in Q4 2024.
  • Funds reported $290M of Usana Health Sciences stock for Q1 2025, down 25% quarter-over-quarter.
  • 31 funds opened new Usana Health Sciences positions in Q1 2025 and 21 closed out, a net change of +10 holders.
  • The largest Usana Health Sciences buyer in Q1 2025 was Millennium Management, an estimated $3.55M added.
  • The largest Usana Health Sciences seller in Q1 2025 was Pacer Advisors, an estimated $14.7M sold.

Based on aggregated 13F filings for Q1 2025.